Global Biomarker Technologies Market:Size, Share, Price, Trend and Forecast to 2026
Summary
The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.
Biomarker is a biological marker, which indicates a substance or a physical event. These indicated substances or events can be measured and the measurements can be further used for the detection of diseases, a physiological change, response to a treatment and a psychological condition. Biomarker technologies are different techniques, which are employed for testing various diseases. These technologies employ the use of different products to measure a biomarker. Reagents and assays are used in various biomarker technologies such as next generation sequencing, polymerase chain reaction, and others. These biomarker technologies are used in various fields of science such as drug discovery, diagnostics, and personalized medicine. Majorly biomarkers are used to detect diseases such as cancer, infectious diseases, autoimmune diseases, neurological disorders, and others.
Rise in prevalence of various diseases such as autoimmune diseases, cancers, and infectious disease boosts the growth of this market. In addition, the rise in research related to drug discovery, increase in healthcare expenditure, and surge in use of personalized medicine are some other factors that contribute toward the growth of this market. The rise in awareness toward the need of early detection of various diseases such as cancers and high growth potential in emerging economies is anticipated to provide lucrative opportunities in the market during the forecast period. However, high initial investment required for biomarker discovery restricts the growth of the biomarker technologies market.
View sample Research Report @
KEY BENEFITS FOR STAKEHOLDERS
-
The study provides an in-depth analysis of the global biomarker technologies market along with the current trends and future estimations to elucidate the imminent investment pockets.
-
A quantitative analysis from 2018 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
-
In-depth analysis of biomarker technologies such as polymerase chain reaction, next generation sequencing, immunoassay and others is carried out in the report.
-
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
• Consumables
• Instruments
By Technology
• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Immunoassay
By Application
• Drug Discovery
• Diagnostics
• Personalized Medicine
By Indication
• Cancer
• Infectious Diseases
• Autoimmune Disorders
• Cardiovascular Disorders
By Region
• North America
• Europe
• Asia-Pacific
• LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• LI-COR, Inc.
• Merck KGAA
• PERKINELMER INC.
• QIAGEN
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.
Get a Full Market Research Report on Biomarker Technologies Market
Category: Healthcare Market Research Report
About Us
JSB market research is one of the most significant databases of online market research and intelligence reports and services. we specialize in providing market research reports for various industries.the online portal for marketing research deals with access to global market data and assists in providing expert.
Contact Us
JSB Market Research
Phone: +917710006748
Website: www.jsbmarketresearch.com
Email: - enquiry@jsbmarketresearch.com